Literature DB >> 30320092

Atypical Retinal Pigment Epithelial Hyperplasia and Glial Proliferation Masquerading as Progressive Recurrent Retinoblastoma: A Case Report Review and Clinicopathologic Correlation.

Emily Zolfaghari1,2, Jonathan W Kim1,2, Subramanian Krishnan2, Patricia Chévez-Barrios3,4,5,6,7, Jesse L Berry1,2.   

Abstract

BACKGROUND: Recurrences of retinoblastoma tumors, particularly scar recurrences, are a common phenomenon in the management of this cancer. Consolidative treatment with laser and cryotherapy are required for local control of disease. It is known that consolidative therapy can induce retinal pigment epithelium (RPE) hyperplasia and gliosis. Herein we report extensive RPE hyperplasia and gliosis during laser therapy for a focal scar recurrence, which presented as a progressive retinal opacification mimicking active retinoblastoma.
METHOD: This is a retrospective case review.
RESULTS: A 2-month-old premature male was diagnosed with sporadic bilateral retinoblastoma (International Intraocular Retinoblastoma Classification [IIRC] group B in the right eye and IIRC group A in the left eye). The patient underwent laser therapy for a focal recurrence which demonstrated a white lesion during therapy and was subsequently enucleated. While there was a focal recurrence and infiltration of the retina (seen both on optical coherence tomography and histopathologic section), the majority of the white, progressive lesion was from extensive RPE hyperplasia and gliosis secondary to laser therapy.
CONCLUSION: Clinicopathologic correlation of the active recurrence and adjacent gliosis is demonstrated.

Entities:  

Keywords:  Glial proliferation; OCT; Recurrent retinoblastoma; Retinal pigment hyperplasia; Retinoblastoma

Year:  2017        PMID: 30320092      PMCID: PMC6167681          DOI: 10.1159/000479741

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  13 in total

1.  Laser Photocoagulation Induces Transduction of Retinal Pigment Epithelial Cells by Intravitreally Administered Adeno-Associated Viral Vectors.

Authors:  Si Hyung Lee; Yoon Jin Kong; Jungmook Lyu; Heuiran Lee; Keerang Park; Tae Kwann Park
Journal:  Hum Gene Ther Methods       Date:  2015-10       Impact factor: 2.396

2.  Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.

Authors:  Carol L Shields; Fairooz P Manjandavida; Sruthi Arepalli; Swathi Kaliki; Sara E Lally; Jerry A Shields
Journal:  JAMA Ophthalmol       Date:  2014-03       Impact factor: 7.389

3.  Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications.

Authors:  Carol L Shields; Carlos G Bianciotto; Pascal Jabbour; Gregory C Griffin; Aparna Ramasubramanian; Robert Rosenwasser; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2011-06-13

Review 4.  Intraocular retinoblastoma: the case for a new group classification.

Authors:  A Linn Murphree
Journal:  Ophthalmol Clin North Am       Date:  2005-03

5.  Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.

Authors:  Wisam J Muen; Judith E Kingston; Fergus Robertson; Stefan Brew; Mandeep S Sagoo; M Ashwin Reddy
Journal:  Ophthalmology       Date:  2011-12-22       Impact factor: 12.079

6.  Toxic effects of melphalan, topotecan and carboplatin on retinal pigment epithelial cells.

Authors:  Daniela Süsskind; Ulrike Hagemann; Merle Schrader; Kai Januschowski; Sven Schnichels; Sabine Aisenbrey
Journal:  Acta Ophthalmol       Date:  2016-02-19       Impact factor: 3.761

7.  Long-Term Outcomes of Group B Eyes in Patients with Retinoblastoma Treated with Short-Course Chemoreduction: Experience from Children's Hospital Los Angeles/University of Southern California.

Authors:  Dagny Zhu; Jesse L Berry; Lilangi Ediriwickrema; Kenneth Wong; Thomas C Lee; A Linn Murphree; Jonathan W Kim; Rima Jubran
Journal:  Ocul Oncol Pathol       Date:  2015-11-05

8.  Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.

Authors:  Carol L Shields; Santosh G Honavar; Jerry A Shields; Hakan Demirci; Anna T Meadows; Thomas John Naduvilath
Journal:  Arch Ophthalmol       Date:  2002-04

Review 9.  Current management strategies for intraocular retinoblastoma.

Authors:  Jonathan W Kim; David H Abramson; Ira J Dunkel
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Diagnosis of retinoblastoma: how good are referring physicians?

Authors:  Jesse L Maki; Brian P Marr; David H Abramson
Journal:  Ophthalmic Genet       Date:  2009-12       Impact factor: 1.803

View more
  1 in total

1.  Progressive Preretinal Fibrosis with Late, Ossifying, Proliferative Retinopathy following Treatment for Retinoblastoma.

Authors:  Minh Nguyen; Jessica Saunders; M Cristina Pacheco; Andrew W Stacey
Journal:  Ocul Oncol Pathol       Date:  2020-09-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.